Back to Journals » Patient Preference and Adherence » Making An Impact in Diabetes Preference and Adherence Research
Patient Preference and Adherence
ISSN: 1177-889X
- View all (2985)
- Volume 18, 2024 (130)
- Volume 17, 2023 (304)
- Volume 16, 2022 (283)
- Volume 15, 2021 (266)
- Volume 14, 2020 (235)
- Volume 13, 2019 (214)
- Volume 12, 2018 (263)
- Volume 11, 2017 (211)
- Volume 10, 2016 (259)
- Volume 9, 2015 (199)
- Volume 8, 2014 (178)
- Volume 7, 2013 (131)
- Volume 6, 2012 (97)
- Volume 5, 2011 (71)
- Volume 4, 2010 (51)
- Volume 3, 2009 (41)
- Volume 2, 2008 (49)
- Volume 1, 2007 (3)
Journal Articles:
- Advancing Medical Problem-Oriented Approaches in Infectious Disease Management (1)
- Treatment adherence in COPD and asthma (10)
- Making An Impact in Diabetes Preference and Adherence Research (3)
- Treatment non-adherence in psychiatric disorders: conceptual and clinical aspects (4)
- Enhancing Medication Safety: Prioritizing Risk Management and Ensuring Safe Dispensing, Prescribing, Pharmacovigilance, and Patient Adherence (1)
- Validation of Patient-Reported Outcome Instruments in Hemophilia (4)
Making An Impact in Diabetes Preference and Adherence Research
Diabetes is a significant clinical and economic burden in the United States and worldwide. According to the Centers for Disease Control and Prevention, 37.3 million Americans have diabetes and 96 million have pre-diabetes. The total costs of diabetes were estimated to be $327 billion in 2017, up from $245 billion in 2012. By 2030, diabetes is estimated to cost $414 billion, or 1.69% of gross domestic product. While research of methods that address diabetes management adherence exists, actual adherence to clinical recommendations remains poor. To address this problem, it is important to take a holistic approach to examine reasons for non-adherence from all stakeholders, including patients, prescribers, institutions, and others. Furthermore, a focus on interventional research to address adherence and its impact on short- and long-term clinical and economic outcomes in high-risk populations is necessary as well.
The Burden of Suboptimal Insulin Dosing in People with Diabetes in Spain: Barriers and Solutions from the Physician Perspective
Bellido V, Duque N, Newson RS, Artime E, Spaepen E, Rubio de Santos M, Redondo-Antón J, Díaz-Cerezo S, Navarro J
Patient Preference and Adherence 2024, 18:151-164
Published Date: 16 January 2024
Evaluating Patient and Provider Preferences for a Once-Weekly Basal Insulin in Adults with Type 2 Diabetes
Kerr D, Rajpura JR, Namvar T
Patient Preference and Adherence 2024, 18:411-424
Published Date: 14 February 2024
Medication Adherence and Its Associated Determinants in Older Adults with Type 2 Diabetes and Cardiovascular Comorbidities
Al-Azayzih A, Kanaan RJ, Altawalbeh SM, Al-Qerem W, Smadi S
Patient Preference and Adherence 2023, 17:3107-3118
Published Date: 29 November 2023